These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32035227)

  • 1. DeepCPI: A Deep Learning-based Framework for Large-scale in silico Drug Screening.
    Wan F; Zhu Y; Hu H; Dai A; Cai X; Chen L; Gong H; Xia T; Yang D; Wang MW; Zeng J
    Genomics Proteomics Bioinformatics; 2019 Oct; 17(5):478-495. PubMed ID: 32035227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples.
    Cheng Z; Zhou S; Wang Y; Liu H; Guan J; Chen YP
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1832-1843. PubMed ID: 28113437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QPoweredCompound2DeNovoDrugPropMax - a novel programmatic tool incorporating deep learning and
    Geoffrey A S B; Madaj R; Valluri PP
    J Biomol Struct Dyn; 2023 Mar; 41(5):1790-1797. PubMed ID: 35007471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting compound-protein interaction prediction by deep learning.
    Tian K; Shao M; Wang Y; Guan J; Zhou S
    Methods; 2016 Nov; 110():64-72. PubMed ID: 27378654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A deep learning method for predicting molecular properties and compound-protein interactions.
    Ma J; Zhang R; Li T; Jiang J; Zhao Z; Liu Y; Ma J
    J Mol Graph Model; 2022 Dec; 117():108283. PubMed ID: 35994925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting drug-target interactions from drug structure and protein sequence using novel convolutional neural networks.
    Hu S; Zhang C; Chen P; Gu P; Zhang J; Wang B
    BMC Bioinformatics; 2019 Dec; 20(Suppl 25):689. PubMed ID: 31874614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. deepDR: a network-based deep learning approach to in silico drug repositioning.
    Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
    Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A general prediction model for compound-protein interactions based on deep learning.
    Ji W; She S; Qiao C; Feng Q; Rui M; Xu X; Feng C
    Front Pharmacol; 2024; 15():1465890. PubMed ID: 39295942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences.
    Tsubaki M; Tomii K; Sese J
    Bioinformatics; 2019 Jan; 35(2):309-318. PubMed ID: 29982330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery.
    Rifaioglu AS; Cetin Atalay R; Cansen Kahraman D; Doğan T; Martin M; Atalay V
    Bioinformatics; 2021 May; 37(5):693-704. PubMed ID: 33067636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
    Redkar S; Mondal S; Joseph A; Hareesha KS
    Mol Inform; 2020 May; 39(5):e1900062. PubMed ID: 32003548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multimodal deep learning framework for predicting drug-drug interaction events.
    Deng Y; Xu X; Qiu Y; Xia J; Zhang W; Liu S
    Bioinformatics; 2020 Aug; 36(15):4316-4322. PubMed ID: 32407508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convolutional neural network based on SMILES representation of compounds for detecting chemical motif.
    Hirohara M; Saito Y; Koda Y; Sato K; Sakakibara Y
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):526. PubMed ID: 30598075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PharmaNet: Pharmaceutical discovery with deep recurrent neural networks.
    Ruiz Puentes P; Valderrama N; González C; Daza L; Muñoz-Camargo C; Cruz JC; Arbeláez P
    PLoS One; 2021; 16(4):e0241728. PubMed ID: 33901196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving compound-protein interaction prediction by building up highly credible negative samples.
    Liu H; Sun J; Guan J; Zheng J; Zhou S
    Bioinformatics; 2015 Jun; 31(12):i221-9. PubMed ID: 26072486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGNDTI: A Drug-Target Interaction Prediction Framework Based on Multimodal Representation Learning and the Gating Mechanism.
    Peng L; Liu X; Chen M; Liao W; Mao J; Zhou L
    J Chem Inf Model; 2024 Aug; 64(16):6684-6698. PubMed ID: 39137398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug-target interactions.
    Wan F; Hong L; Xiao A; Jiang T; Zeng J
    Bioinformatics; 2019 Jan; 35(1):104-111. PubMed ID: 30561548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.
    Wang L; Ma C; Wipf P; Liu H; Su W; Xie XQ
    AAPS J; 2013 Apr; 15(2):395-406. PubMed ID: 23292636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BACPI: a bi-directional attention neural network for compound-protein interaction and binding affinity prediction.
    Li M; Lu Z; Wu Y; Li Y
    Bioinformatics; 2022 Mar; 38(7):1995-2002. PubMed ID: 35043942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.